Clinical Manufacture

Commercial Manufacture

Drug Product Fill & Finish

Development

Testing

Discovery

Antibody Drug Conjugates

Technologies & Platforms

Corporate Information        中文

Company Name WuXi Biologics (Cayman) Inc.
Registered Office PO Box 309
Ugland House
Grand Cayman KY1-1104
Cayman Islands
Principal Place of Business in Hong Kong Level 54, Hopewell Centre
183 Queen’s Road East
Hong Kong
Headquarters and Principal Place of Business in China No. 88 Meiliang West Road
Mashan
Wuxi
China
Sector Medical
Web Site Address http://www.wuxibiologics.com
Phone Number (852) 2980 1888
Fax Number (852) 2861 0285
Email Address ir@wuxibiologics.com
Financial Year End December 31
Board of Directors Executive Directors
Dr. Zhisheng Chen (Chief executive officer)
Dr. Weichang Zhou (Chief technology officer)

Non-executive Directors
Dr. Ge Li (Chairman)
Mr. Edward Hu
Mr. Yibing Wu
Mr. Yanling Cao

Independent Non-Executive Directors
Mr. William Robert Keller
Mr. Teh-Ming Walter Kwauk
Mr. Wo Felix Fong

Joint Company Secretaries Mr. Yong Tong
Ms. Cheng Pik Yuk (HKICS, ICSA)
Principal Bankers China Construction Bank
Bank of Communications
Citibank N.A. Hong Kong Branch
Auditors Deloitte Touche Tohmatsu
Certified Public Accountants
35/F One Pacific Place
88 Queensway
Hong Kong
Legal Advisers as to Hong Kong and U.S. law:
Wilson Sonsini Goodrich & Rosati
Suite 1509, 15/F, Jardine House
1 Connaught Place
Central
Hong Kong

as to PRC law:
Fangda Partners
32/F, Plaza 66 Tower 1
1266 Nan Jing West Road
Shanghai
China

as to Cayman Islands law:
Maples and Calder (Hong Kong) LLP
53/F, The Center
99 Queen’s Road Central
Hong Kong

Principal Share Registrar and Transfer Office Maples Fund Services (Cayman) Limited
PO Box 1093, Boundary Hall
Cricket Square
Grand Cayman KY1-1102
Cayman Islands
Hong Kong Share Registrar Tricor Investor Services Limited
Level 22, Hopewell Centre
183 Queen’s Road East
Hong Kong
HKEX Stock Code 2269
Listing Date 13th June, 2017
BACK